This paper reviews the recent studies and development of mesenchymal stem cell (MSCs) therapy for neurodegenerative diseases. MSCs transplantation, a promising therapy, can promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons in animal models and patients with neurodegenerative diseases. In this review, we introduce briefly the potential benefits of MSCs. Finally, the possibility of clinical application in neurodegenerative diseases is also discussed.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: